Overview

Effects of Psilocybin in Obsessive Compulsive Disorder

Status:
Not yet recruiting
Trial end date:
2026-09-12
Target enrollment:
Participant gender:
Summary
This study will test the feasibility, safety, and evidence for efficacy of psilocybin administration in participants with obsessive compulsive disorder (OCD). This will serve as a preliminary proof of concept study for future larger studies aimed to investigate the utility, cognitive mechanisms, and neural correlates of this intervention.
Phase:
Early Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Psilocybin